Using AI to recommend treatments for gastrointestinal cancers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of ChatGPT in suggesting treatment plans for patients with gastrointestinal cancers by analyzing both retrospective and prospective data. Medical records from over 1,200 patients will be collected, with a portion used to explore various prompt methods for treatment recommendations. A multidisciplinary team will assess the AI's suggestions against those of clinicians. Additionally, 400 participants will be randomly assigned to receive either clinician-only recommendations or ChatGPT-assisted plans, allowing for a comparison of treatment outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥18 years, both male and female.
* Pathologically confirmed diagnosis of gastrointestinal cancer (gastric cancer or colorectal Cancer).
* Detailed medical records available prior to treatment (including chief complaint, history of present illness, radiological examinations, pathological examinations, laboratory tests, etc.).
* Participants will receive complete treatment in the participating hospitals.

Exclusion Criteria:

* Participants with cancers other than gastrointestinal cancers.
* Participants who receive treatment in multiple hospitals.

Where it's running

• Jiangmen Central Hospital
  Jiangmen, Guangdong, China Recruiting
• The Fifth Affiliated Hospital of Sun Yat-sen University
  Zhuhai, Guangdong, China Recruiting
• Zhuhai People's Hospital
  Zhuhai, Guangdong, China Recruiting
• Peking University Cancer Hospital (Inner Mongolia Campus)
  Hohhot, Inner Mongolia, China Recruiting
• City of Hope
  Duarte, California, United States Not yet recruiting
• University Hospital Magdeburg
  Magdeburg, Saxony-Anhalt, Germany Not yet recruiting

Study contacts

• Principal investigator: Di Dong, PhD — Institute of Automation, Chinese Academy of Sciences
• Study coordinator: Di Dong, PhD
• Email: di.dong@ia.ac.cn
• Phone: +86 13811833760

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Telephone support for patients with advanced gastrointestinal cancer

  This study is testing whether a telephone counseling program can help patients with advanced gastrointestinal cancer and their caregivers manage stress and fatigue better than standard support.

  Recruiting at 4 sites Indiana University · Chicago, Illinois and 3 other locations · NCT06532877

• Multicenter chest X-ray screening for thoracic diseases

  This project will test whether routine chest X-rays can detect thoracic problems in adults who come for routine health examinations.

  Recruiting Chinese Academy of Sciences · Dazhou, Sichuan · NCT07585214

• AI-based CT prediction of microvascular invasion in liver cancer

  This project will test whether an AI-powered tool using preoperative multiphase CT can predict microvascular invasion in adults with hepatocellular carcinoma who are scheduled for surgery.

  Recruiting at 19 sites Chinese Academy of Sciences · Fuzhou, Fujian and 18 other locations · NCT07170345

• Real-time AI labeling of critical anatomy during laparoscopic gallbladder removal

  This project will try a real-time AI algorithm to label key anatomical structures in laparoscopic cholecystectomy videos to help surgeons avoid bile duct injuries.

  Recruiting at 5 sites Chinese Academy of Sciences · Zhengzhou, Henan and 4 other locations · NCT07158372

• Protein supplements with semaglutide and a calorie-restricted diet for weight loss

  This will test whether adding daily protein supplements to semaglutide plus a calorie-restricted diet helps adults with overweight or obesity lose more weight, preserve muscle, and reduce weight regain.

  Recruiting Chinese Academy of Sciences · Hangzhou, Zhejiang · NCT06989203

• Probiotic or semaglutide plus diet to reduce body weight

  This project will test whether adding a probiotic (Lactobacillus paracasei LC-19) or semaglutide to a calorie-restricted diet helps overweight adults lose weight and improve blood sugar and lipid levels.

  Recruiting Chinese Academy of Sciences · Hangzhou, Zhejiang · NCT06989177

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.